| AML | Acute myeloid leukemia |
| CCRCC | Clear cell renal cell carcinoma |
| CENP-C | Centromeric protein C |
| CIMP | CpG island methylator phenotype |
| CRC | Colorectal cancer |
| DFS | Disease-free survival |
| EC | Endometrial carcinoma |
| EEC | Endometrioid endometrial carcinoma |
| EGFR | Epidermal growth factor receptor |
| FAK | Focal adhesion kinase |
| FISH | Fluorescence in situ hybridation |
| GISTIC | Genomic identification of significant targets in cancer |
| GBM | Glioblastoma |
| IHC | Immunohistochemistry |
| IL | Interleukin |
| KIRC | Kidney renal papillary carcinoma |
| KRAS | Kirsten rat sarcoma |
| LGG | Lower grade gliomas |
| MAN2C1 | α-mannosidase 2C1 |
| MAPK | Mitogen-activated protein kinase |
| mCRC | Metastatic colorectal cancer |
| MEK | Mitogen-activated protein kinase kinase |
| miRNA | Micro RNA |
| MMP | Matrix metalloproteinase |
| MSI | Microsatellite instability |
| mTOR | Mammalian target of rapamycin |
| OS | Overall survival |
| PBD | PIP2-binding domain |
| PD-1 | Programmed death-1 |
| PD-L1 | Programmed death ligand-1 |
| PDAC | Pancreatic ductal adenocarcinoma |
| PI3K | PhosphatidylInositol 3-kinase |
| PTEN | Phosphatase and tensin homolog deleted on chromosome 10 |
| PICT-1 | Protein interacting with carboxyl terminus 1 |
| PIP2 | PhosphatIdylinositol-4,5-bisphosphate |
| PIP3 | Phosphatidylinositol-3,4,5-trisphosphate |
| RCC | Renal cell carcinoma |
| TCGA | The cancer genome atlas |
| TMA | Tissue microarray |
| TME | Tumor microenvironment |
| TNM | Tumor, node, metastasis |
| UCEC | Uterine corpus endometrial carcinoma |